Feature|Videos|January 2, 2025
Looking Towards the Future of CAR T-cell Trials
Delivering the same safe product to a patient while improving timelines of clinical trials
Advertisement
Episodes in this series
The panelists explain how they hope CAR T-cell clinical trials will improve over time. Tactics like developing scalable manufacturing techniques, having adaptive manufacturing, streamlining regulatory approval, and gaining early feedback from regulatory bodies will help quicken clinical trial processes.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors
2
Executive Order Cuts Recommended Childhood Vaccines Down to 11: Report
3
BeOne Medicines Enters Collaboration with Revolution Medicines for Oncology Therapies
4
The Science of Targeting Multiple Immune Components in ITP: Q&A with Dr. Srikanth Nagalla
5